Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Amortizatization of Intangibles (2016 - 2025)

Vanda Pharmaceuticals' Amortizatization of Intangibles history spans 16 years, with the latest figure at $1.7 million for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 2.74% year-over-year to $1.7 million; the TTM value through Dec 2025 reached $7.0 million, down 4.05%, while the annual FY2025 figure was $7.0 million, 3.66% down from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was $1.7 million at Vanda Pharmaceuticals, down from $1.8 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $3.8 million in Q2 2023 and bottomed at -$2.5 million in Q4 2023.
  • The 5-year median for Amortizatization of Intangibles is $574500.0 (2021), against an average of $1.0 million.
  • The largest annual shift saw Amortizatization of Intangibles skyrocketed 1022.22% in 2022 before it crashed 238.61% in 2023.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$198000.0 in 2021, then surged by 1022.22% to $1.8 million in 2022, then plummeted by 238.61% to -$2.5 million in 2023, then surged by 169.22% to $1.8 million in 2024, then decreased by 2.74% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for VNDA's Amortizatization of Intangibles are $1.7 million (Q4 2025), $1.8 million (Q3 2025), and $2.8 million (Q2 2025).